Cortical D2 dopamine receptor (Drd2) have mostly been examined in the context of cognitive function regulation and neurotransmission modulation of medial prefrontal cortex by principal neurons and parvalbumin positive, fast-spiking, interneurons in schizophrenia. Early studies suggested the presence of D2 receptors in several cortical areas, albeit with major technical limitations. We used combinations of transgenic reporter systems, recombinase activated viral vectors, quantitative translatome analysis and high sensitivity in situ hybridization to identify D2 receptor expressing cells and establish a map of their respective projections. Our results identified previously uncharacterized clusters of D2 expressing neurons in limbic and sensory regions of the adult mouse brain cortex. Characterization of these clusters by translatome analysis and cell type specific labeling revealed highly heterogeneous expression of D2 receptors in principal neurons and various populations of interneurons across cortical areas. Transcript enrichment analysis also demonstrated variable levels of D2 receptor expression and several orphan G-protein-coupled receptors co-expression in different neuronal clusters, thus suggesting strategies for genetic and therapeutic targeting of D2 expressing neurons in specific cortical areas. These results pave the way for a thorough reexamination of cortical D2 receptor functions, which could provide information about neuronal circuits involved in psychotic and mood disorders. Khlghatyan, Quintana et al.
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raclopride has demonstrated the presence of D2 binding regions throughout cortex (Lidow MS et al. 1989 ). Expression of Drd2 in different cortical areas have also been reported (Vincent SL et al. 1993; Gaspar P et al. 1995; Le Moine C and P Gaspar 1998; Santana N et al. 2009; Zhang ZW et al. 2010; Gee S et al. 2012; Tritsch NX and BL Sabatini 2012) , albeit with severe technical limitations due to low mRNA expression and selectivity of antibodies or reporter systems (Tritsch NX and BL Sabatini 2012) . Thus, a systematic multimodal, cortex-wide characterization of Drd2 expression still has to be performed to clarify the nature and abundance of Drd2 expressing cells in different cortical regions.
To overcome previous technical limitations we used mice expressing a Cre activated RiboTag, specifically in Drd2 positive (Drd2+) cells (Sanz E et al. 2009; Puighermanal E et al. 2015) . RiboTag mice carry a ribosomal protein Rpl22 allele with a floxed wild-type C-terminal exon followed by an identical C-terminal exon that has three HA epitopes inserted before the stop codon. Notably, Rpl22-HA is expressed under the control of its own promoter. Thus, in contrast to analog systems in which reporter protein expression is proportional to Drd2 promoter activity, these mice allow for a highly sensitive, all or none (binary) detection of Drd2+ neurons throughout the brain. Furthermore, the possibility to perform cell-specific translational profiling (Brichta L et al. 2015) provides a direct quantification of endogenous Drd2 mRNA translation in neurons expressing the RiboTag reporter.
Our results revealed previously uncharacterized clusters of Drd2+ cells in limbic and sensory cortical regions of the adult mouse brain. Further analysis quantitatively and qualitatively validated the presence of Drd2 mRNA as well as indicated molecular and cellular heterogeneity of Drd2+ clusters across the cortex. Projection tracing using virally encoded reporters was also used to establish a general map of Drd2 neurons connections that may provide dorsoventral -1.7 -3 -2.9 -2.9 -0.5 -0.5 -0.5 1 0
Immunohistochemistry
Mice were euthanized 3 weeks after stereotaxic surgery by a lethal dose of ketamine/xylazine and perfused with phosphate buffer saline (PBS) followed by 4% paraformaldehyde (PFA). Brains were incubated in 4% PFA 24h at 4°C. Fixed tissue was sectioned using vibratome (Leica, VT1000S). Next, 40µm sections were washed 3 times for 5 min in PSB. Sections were blocked and incubated with a permeabilization solution containing 5% normal goat serum (Millipore) and 0.5% Triton X-100 (Sigma) in PBS for 2h. Sections were then incubated with primary antibodies diluted in permeabilization solution overnight at 4°C.
After three washes in PBS, slices were incubated with secondary antibodies for 2h at room temperature. Sections were rinsed three times for 10 min in PBS before mounting with DAKO mounting medium (DAKO). Staining was visualized using either near-infrared laser scan imaging with an Odyssey Imaging System (LiCor) or confocal microscope (Zeiss LSM 700 or Zeiss LSM 880, Zen 2011 Software).
Following primary antibodies were used: Mouse anti-NeuN (1:500, Millipore MAB377), mouse anti-Calretinin (1:500, Chemicon MAB1578), rabbit anti-Neuropeptide Y (1:500, Sigma N9528), mouse anti-Calbidin (1:500, Sigma C9848), mouse anti-Parvalbumin (1:500, Sigma P3088), rabbit anti-Somatostatin (1:500, Diasoron Inc. 21574), mouse anti-GFP (1:1000, Invitrogen A11120), rabbit anti-Ds Red (1:500, Clontech 632496), mouse anti-HA (1:500, Biolegend MMS-101R-200), rabbit anti-HA (1:500, Sigma H6908), chicken anti-HA (1:500, Abcam Ab9111), rabbit anti-Tyrosine hydroxylase (1:1000, Millipore AB152), rat anti- Following secondary antibodies were used: Goat anti-mouse, rabbit, chicken, rat Alexa 488, 568, 647 (1:500, Invitrogen), goat anti-mouse IR Dye 680 (1:10000, Mandel).
RNAscope in situ hybridization
Fluorescent in situ hybridization (FISH) for Drd2 mRNA (Probe #406501) and Negative Control (Probe #320871) was performed using the RNAscope ® Fluorescent Multiplex 2.0 assay as per the manufacturer's instruction (Advanced Cell Diagnostics, Hayward, CA, USA). Briefly, fresh whole mouse brains were embedded in OCT medium and quickly frozen in isopentane (2methylbutane) chilled to -80°C. Twenty-micrometer cryosections of brain tissues were then prepared and mounted on SuperFrost Plus slides. Sections were fixed and pre-treated according to the RNAscope ® guide for a fresh frozen tissue. After pre-treatment, sections were hybridized with Drd2 and Negative control probes using the HybEZ Hybridization System. After several amplification sets, the sections were counterstained with DAPI and mounted using DAKO.
Images were acquired on an LSM880 confocal microscope (Carl Zeiss).
Statistical analysis
Data are presented as means ± SEM. Two-tailed t test is used in GraphPadPrism 5 software for comparison between two groups (La Jolla, CA) (*p < 0.05, **p < 0.01, ***p < 0.001).
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Results
The Drd2 positive cell clusters are present throughout the cerebral cortex RiboTag mice were crossed with BAC D2Cre mice (Gerfen CR et al. 2013) resulting in activation of epitope-tagged ribosomal protein Rpl22-HA under the control of its own promoter and its incorporation into ribosomes (Sanz E et al. 2009) D2 EGFP mice are a commonly used BAC transgenic analog reporter system, where GFP is expressed under the control of the Drd2 promoter (Gong S et al. 2003 EGFP mice did not allow for visualization of all identified cortical cluster and showed few cells in mPFC, CL/INS and no cells in, SS, AUD, and VIS ( Supplementary Fig. 1 ). This difference may arise from the high sensitivity of the RiboTag reporter system as compared to D2GFP.
However, one caveat of a Cre reporter system is that gene promoters can be transiently activated during brain development (Thompson CL et al. 2014) . Thus, it is also possible that Drd2+ cell clusters in different cortical regions of RiboTag::D2Cre mice may consist mostly of cells that were labeled as a result of transient Cre activation during brain development. the cells that were infected with viruses. This triple labeling allowed for the quantification of the co-infection rate of mCherry+ cells by GFP expressing virus (mCherry+GFP+ out of all mCherry+) and the percentage of HA+ cells expressing Cre in adulthood (mCherry+HA+GFP+ out of all HA+GFP+) ( Fig. 2A ). Co-infection rate of mCherry+ cells by GFP expressing virus was close to 80% in most cortical regions (Fig. 2B ). This supports the use of GFP expression as a reliable marker for virus-infected cells. Furthermore, 80 to 100% of virus-infected HA+ cells (HA+/GFP+) were also mCherry+ (mCherry+/HA+/GFP+) depending of cortical region ( Fig.   2B ). Overall, this indicates that more than 80% of reporter-labeled (HA+) cells also display Cre recombinase activity during adulthood, thus confirming that Rpl22-HA expression is representative of adult Cre expression in these cortical areas.
Expression of Cre recombinase in Drd2 cells during adulthood

Drd2 mRNA is expressed in multiple cortical regions
To demonstrate and quantify Drd2 expression directly in reporter-labeled cells (HA+), HA-tagged ribosomes were immunoprecipitated (RiboTag-IP) from the different HA positive cortical clusters. For qualitative PCR, primers that amplify from exon 4 to 6 of the Drd2 transcript were designed, allowing to distinguish between D2S (missing exon 5) and D2L mRNAs are present in all HA positive cortical regions identified in the adult mouse brain.
Molecular heterogeneity of Drd2 cells across different cortical regions.
Striatal Drd2 cells have been shown to co-express different genes that can sometimes be used as proxies for Drd2 expression. To compare the gene expression profiles between Drd2 cells of STR and various cortical regions several transcripts were selected. GPCRs, such as 1 6
Adora2A, Gpr88, Gpr52, and Gpr6 have been shown to be the most enriched in the striatum, 4B ). However, the picture was different for other targets across various regions. show high expression of pyramidal neuron markers: Vesicular glutamate transporter 1 (Vglut1 or Slc17a7), T-box brain gene 1 (Tbr1), neurogenic differentiation factor 1, 2, and 6 (NeuroD1, NeuroD2, NeuroD6) (Hevner RF et al. 2006; Molyneaux BJ et al. 2007 
Cellular heterogeneity of Drd2 clusters in different cortical regions
Translational profiling data suggests that Drd2 is expressed in principal neurons and in several interneuron subtypes of mPFC. Double immunofluorescent staining of HA in combination with several cell type selective markers was thus performed in brain slices of D2Cre+RiboHA+ mice to identify cell types that express Drd2 across all the cortical clusters and quantify their representation in the total pool of the cells in each region. NeuN and HA colabeling confirmed that all Drd2 expressing cells are neurons ( Fig. 5A, B ).
Five different phenotypic markers were then used to identify interneuron subtypes that express Drd2: calretinin (CalR), neuropeptide Y (NPY), PV, somatostatin (SOM) and calbindin (CalB) ( Fig. 5B , C, and Supplementary Fig. 2 ). Interneurons accounted only for a small portion 1 8
of Drd2+ cells in all cortical regions ( Fig. 5B , Supplementary Fig. 2 ). This suggests that the vast majority of Drd2 expressing cells are principal neurons.
Assuming that high representation of Drd2+ cells could be indicative of an important functional implication, the proportion in each cell subtype was quantified. Depending on the region, 20-85% of all NeuN positive cells expressed Drd2 (Fig. 5C ). Drd2+ neurons were represented unevenly in various interneuron subtypes across cortical regions ( Fig. 5C , Supplementary Fig. 2 ). For example, 30-50% of different types of interneurons in mPFC layer II, V, Cg, SS, AUD, and VIS also expressed Drd2, few interneurons expressed Drd2 in CL/INS while in regions like EP and Ent, almost no Drd2+ interneurons were detected ( Fig. 5C , Supplementary Fig. 2 ). Overall, this indicates that Drd2 is expressed in different heterogeneous neuronal populations and that these populations vary across cortical regions.
The dopaminergic input of Drd2 cells from different cortical regions
We then investigated whether cortical clusters of Drd2 cells receive dopaminergic input.
Brain sections were immunostained for tyrosine hydroxylase (TH) and dopamine active transporter (DAT) to detect dopamine neuron terminals. TH labeled fibers were detected in all regions, with the highest density and labeling intensity in CL/INS and STR ( Fig. 6A ). In contrast, DAT labeled fibers were only visible in STR (Fig. 6B ). The absence of DAT staining in cortical TH positive termini has previously been reported (Sesack SR 2014), suggesting that in absence of DAT other monoamine transporters can participate in dopamine reuptake (Morón JA et al. 2002; Smith CC and RW Greene 2012) . Indeed, we have detected the presence of norepinephrine transporter (NET) in all the cortical regions. Moreover, a fraction of TH+ fibers in those regions were also NET+ ( Supplementary Fig. 3 ).
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Projection targets of Drd2 cells from different cortical regions
The direct projection targets of Drd2+ cortical neurons were mapped to characterize the position of Drd2+ cell clusters in the wider context of brain connectivity. AAV hSyn-EGFP and AAV hSyn-DIO-mCherry viruses were mixed and injected into different cortical regions in D2Cre mice ( Fig. 7 , Supplementary Fig. 4-9 ). GFP and mCherry were visualized on coronal serial sections by confocal microscopy to identify: Drd2+ neurons that are labeled by both GFP and mCherry and appear yellow, and Drd2 negative neurons (Drd2-) that are labeled only by GFP ( Fig. 7 , Supplementary Fig. 4-9 ). Maps of Drd2+ and Drd2-neuron projections from cortical clusters were created ( Fig. 7 , Supplementary Fig. 4-9 ). High magnification images resolving cell bodies or axonal varicosities were taken to verify the injection and projection sites respectively ( Fig. 7 , Supplementary Fig. 4-9 ). Projections from all regions are schematically summarized in Fig. 8 .
For the mPFC, Drd2+ and Drd2-neurons project to the same targets: contralateral mPFC Supplementary Fig. 5E ). However, Drd2+ neurons do not project to controlateral mPFC, INS ( Supplementary Fig. 5A ) and SN ( Supplementary Fig. 5F ). For the AUD, Drd2+, and Drd2-neurons project to STR ( Supplementary Fig. 8E ).
However, Drd2+ neurons do not project to THAL ( Supplementary Fig. 8E-F ).
For the VIS, Drd2+, and Drd2-neurons project to STR ( Supplementary Fig. 9B Supplementary Fig. 9F ). However, Drd2+ neurons do not project to certain thalamic nuclei ( Supplementary Fig. 9D -E).
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Discussion
We used a highly sensitive, multimodal approach to map Drd2 expressing neurons in a cortex-wide fashion. The use of a binary reporter mouse and a Cre dependent virus uncovered previously uncharacterized clusters of Drd2+ cells in mPFC, CL, SS, AUD, and VIS. The Fig. 5, Supplementary Fig. 2 ). Moreover, up to 40% of interneurons (depending on subtype) express Drd2 ( Fig. 5, Supplementary Fig. 2 ). Interestingly, expression of Drd2 was not limited to PV+ cells but was more frequently observed in other subtypes of interneurons, mostly NPY+ and SOM+ ( Fig. 5, Supplementary Fig. 2 ). This data is in line with our translatome analysis ( Fig. 4H , Supplementary Table 1 ). Drd2+ cortical clusters with a proportion among NeuN+ cells ranging from 20% to 85% ( Fig. 5 , Supplementary Fig. 2 ). The proportion of Drd2+ cells among different types of interneurons also varied among cortical brain regions ( Fig. 5, Supplementary Fig. 2 ). This indicates that PV+ cells cannot account for a majority of Drd2+ interneurons in the mPFC or other cortical regions.
By using AAV mediated tracing, we constructed a general map of the Drd2+ neuron projections ( Fig. 7, 8 , Supplementary Fig. 4-9 ). Our results show that Drd2+ neurons do not always follow the characteristic pattern of projection of the region where they reside. These results may point to the possible function of Drd2+ cells of a certain brain region. However, more detailed tracing for each region has to be performed. For instance, by quantitatively comparing the innervations of a given region by Drd2+ cells to the innervations by other cells from the same brain area. This may indicate whether an area is preferentially innervated by Drd2+ cells, thus providing deeper insight into the role of Drd2+ cells in a given network.
When analyzing the presence of dopaminergic fibers, we noted that all the regions receive TH immunoreactive innervation, while DAT staining was undetectable ( Fig. 6 ). All the cortical regions were also innervated to various degrees by NET+ fibers. Moreover, a fraction of TH+ fibers were also NET+ ( Supplementary Fig. 3 Our investigation revealed the existence of clusters of Drd2+ neurons in the CL/INS, SS, AUD, and VIS (Fig. 1) . Interestingly, certain symptoms of schizophrenia can be linked to these 5  5  :  2  2  3  -2  3  3  .   I  t  o  K  ,  S  a  n  o  s  a  k  a  T  ,  I  g  a  r  a  s  h  i  K  ,  I  d  e  t  a  -O  t  s  u  k  a  M  ,  A  i  z  a  w  a  A  ,  U  o  s  a  k  i  Y  ,  N  o  g  u  c  h  i  A  ,  A  r  a  k  a  w  a  H  ,  N  a  k  a  s  h  i  m Khlghatyan, Quintana et al. Drd2 and a negative control probe on mouse brain slices. Note that every little point represents a mRNA of Drd2, highlighted by the arrow. Scale bar is 100µm. Drd2+ cell projections from different cortical regions (shown in Fig.7 and Supplementary Fig. 4-9 ) are summarized.
